New Company, FlexPath DXP, Launches Turnkey FinTech Platform to Power End-to-End Connected Retailing
FlexPath DXP (Digital Experience Platform) connects Modern Retailing and eCommerce components of Digital Marketing and Personalized Shopping CINCINNATI–(BUSINESS... Read more.
o9 Announces Make a Difference (MAD) as the Recipient of Its Inaugural Digital Tomorrow Grant
MAD, a prominent India-based nonprofit organization, was selected for its innovative tech-enabled mentorship project DALLAS–(BUSINESS WIRE)–o9, a leading... Read more.
96% of SMBs Using TikTok Receive More Engagement Than on Instagram
TikTok emerges as the top marketing platform for SMBs, offering superior ROI and audience interaction, finds Capterra’s TikTok Marketing Survey. ARLINGTON, Va.–(BUSINESS... Read more.
Todd Schwartz Joins Alliant Insurance Services as Senior Vice President, Based in Miami
20-year industry veteran serves risk management needs of nationwide client base IRVINE, Calif.–(BUSINESS WIRE)–#Alliant–Todd Schwartz has joined... Read more.
High-Quality, Long-Term Foreign Investment Boosts Xiamen’s Growth
XIAMEN, China–(BUSINESS WIRE)–Morten Wierod, president of the electrification business area of ABB Ltd, a Switzerland-based technology company, announced... Read more.
WEX Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
PORTLAND, Maine–(BUSINESS WIRE)–WEX Inc. (NYSE: WEX), the global commerce platform that simplifies the business of running a business, today announced... Read more.
Williams to Report Fourth-Quarter and Full-Year 2023 Financial Results Feb. 14; will host Clean Energy Expo Feb. 13 and Analyst Day event Feb. 14 in Washington D.C.
TULSA, Okla.–(BUSINESS WIRE)–Williams (NYSE: WMB) will host a Clean Energy Expo in Washington D.C. on Tuesday, Feb. 13, focused on how Williams and the... Read more.
Exelixis Announces Detailed Results of Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer Presented at ASCO GU 2024
– Cabozantinib in combination with atezolizumab reduced the risk of disease progression or death by 35% in patients with metastatic castration-resistant prostate... Read more.
Plastic Collective attracts landmark fundraising to tackle plastic pollution
LONDON & WASHINGTON–(BUSINESS WIRE)–Plastic Collective, a leading social enterprise focused on solving the plastic waste epidemic, is pleased to... Read more.
Domain Therapeutics Awarded Hospital-University Research in Health (RHU) SPRINT Consortium Grant to Progress Its Proprietary CCR8 Antibody Candidate to the Clinic
Domain to receive a grant over a five year period to support DT-7012 which is expected to start a Phase I study by mid-2025 DT-7012, a Treg depleting anti-CCR8 monoclonal... Read more.